ARTICLE | Clinical News
Renin-angiotensin system regulatory update
June 9, 2014 7:00 AM UTC
In April, PRAC supported the conclusions of an EMA review, which concluded in February 2012 that aliskiren plus an ACE inhibitor or ARB could increase the risk of side effects on the heart, circulatio...